Company Overview of Sarepta Therapeutics, Inc.
Richard Jon Barry
Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee, Sarepta Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 3 Board Members in 3 different organizations across 4 different industries.|
See Board Relationships
215 First StreetPhone: 617-274-4000
Cambridge, Massachusetts 02142
Board Members Memberships
Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
Pennsylvania State University
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Chairman of Agenda Committee|
Ionis Pharmaceuticals, Inc.
|John M. Maraganore M.D., Ph.D.||Chief Executive Officer and Executive Director|
Alnylam Pharmaceuticals, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Executive Director|
Arbutus Biopharma Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|$490.0K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.